FINWIRES · TerminalLIVE
FINWIRES

Sansure Biotech Gets Device Registration Certificate for COVID-19, Flu, RSV Detection Kits

By

Sansure Biotech (SHA:688289) received a medical device registration certificate from China's National Medical Products Administration for its nucleic acid detection kits for COVID-19, influenza A and B, and respiratory syncytial virus, according to a Thursday disclosure to the Shanghai bourse.

The kit is the company's first approved lyophilized nucleic acid detection reagent for respiratory infections, Sansure said in its filing.

Related Articles